Search

everythinglearnresearchcommunity

for

Search:↓

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Fungal infections are common in severe COVID-19 cases but their impact on disease severity is unclear.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Global collaboration in dermatology improved data sharing and patient care during COVID-19.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Antiandrogens don't help with COVID-19 and aren't recommended.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Racial minorities faced more Covid-19 blame due to anti-fatness and structural racism.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

AGA might indicate higher risk for severe COVID-19.